Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 18, 2020Journal of the European Academy of Dermatology and VenereologyOpen Access

Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials

View Full Paper
Ask AI
Bookmark
Share

Authors

TBThomas R.M. BieberJTJacob Pontoppidan ThyssenKRKristian Reich

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bieber et al. (2020) studied this question.

synapsesocial.com/papers/6ab9ef8f6afc7ff22676e293https://doi.org/10.1111/jdv.16948
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials2020 · 393 citations